北京中泰邦

Beijing Zhongtaibang Pharmaceutical Technology is a specialized pharmaceutical company focused on transdermal anesthesia and topical drug delivery systems. Founded in 2019 and headquartered in Beijing's Yanqing District, the company operates a 23,500-square-meter facility equipped with five GMP production lines for creams, patches, gels, aerosols, and sterile preparations. Its flagship commercial product, Compound Lidocaine Cream, generates approximately 300 million RMB in annual sales and is widely utilized in medical aesthetics, urology, and gynecology. The company's R&D pipeline includes a Phase 3 Lidocaine Ointment for post-circumcision analgesia and a novel Class I drug for perianal anesthesia. Additionally, Zhongtaibang provides CDMO services, recently expanding its capabilities to include the contract manufacturing of sterile carbomer gels.